CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 143 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2016. The put-call ratio across all filers is 0.84 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $0 | -100.0% | 600 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | -50.0% | 600 | 0.0% | 0.00% | – |
| Q4 2017 | $2,000 | 0.0% | 600 | 0.0% | 0.00% | -100.0% |
| Q3 2017 | $2,000 | +100.0% | 600 | 0.0% | 0.00% | – |
| Q2 2017 | $1,000 | -50.0% | 600 | 0.0% | 0.00% | -100.0% |
| Q1 2017 | $2,000 | 0.0% | 600 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $2,000 | 0.0% | 600 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $2,000 | -33.3% | 600 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $3,000 | +50.0% | 600 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $2,000 | -66.7% | 600 | +50.0% | 0.00% | -83.3% |
| Q4 2015 | $6,000 | +50.0% | 400 | 0.0% | 0.01% | +200.0% |
| Q3 2015 | $4,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Byrne Asset Management LLC | 86 | $2,000 | 0.00% |